Reviewer
Eswar Shankar
Case Western Reserve University, USA
About
As published by the journal they serve.
Cancer biologist with 10 years’ experience in academic research. Extensive experience working in small molecules, ligands, and natural compounds as chemotherapeutic agents in prostate, kidney, bladder, breast and ovarian cancers. Strong background in signal transduction, chemoprevention, chemo-resistance and inflammation. Significant contributions include identifying the role of: Protein Kinase C epsilon as a pivotal inhibitor of TRAIL induced cell death in breast cancer, NSC109268 as an agent inducing Cisplatin sensitivity in ovarian cancer, High Fat Diet induced inflammation as a cause for prostate cancer, Survivin/TGF-β/mTORC1 Axis in prostate epithelial cell growth. Key findings demonstrated through 15 peer reviewed publications. Serving as a reviewer for PLOSE ONE, Journal of Cancer Therapy (JCT) and Journal of Cancer Science and Therapy. Previous work experience is in quality assurance in medical device/bulk drug industries from India.
Journals they serve
The seats these journals name them in.
- Cancer Science & TherapyReviewer
Articles we hold
Articles in the journals they serve whose byline carries this name.
No article in our collection carries this name on its byline. Not every article names its authors in a way that can be matched, so this is not a list of everything they have written.
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.
